pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 766 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    EBC-129
    Pancreatic Ductal Adenocarcinoma Agency for Science, Technology and Research
  • Phase 1
    EG-001
    Idiopathic Interstitial Pneumonia (IIP) Shenzhen Evergreen Therapeutics Co Ltd
  • Phase 1
    EG-009
    Coronavirus Disease 2019 (COVID-19) Associated Cytokine R… Shenzhen Evergreen Therapeutics Co Ltd
← prev
page 9 of 26
next →
131
Pain89
Neurology1
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
  • Phase 1
    EL-22
    Obesity Northstrive Biosciences Inc
  • Phase 1
    ELVN-001
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)$ELVN Enliven Therapeutics, Inc.
  • Phase 1
    ENS-002
    Atopic Dermatitis (Atopic Eczema) Concerto Biosciences Inc
  • Phase 1
    ENV-308
    Obesity Enveda Biosciences Inc
  • Phase 1
    ENV-6946
    Inflammatory Bowel Disease Enveda Biosciences Inc
  • Phase 1
    EO-2002
    Corneal Edema Emmecell LLC
  • Phase 1
    ER-100
    Non-Arteritic Anterior Ischemic Optic Neuropathy Life Biosciences Inc.
  • Phase 1
    ERAS-4001
    Solid Tumor$ERAS Erasca, Inc.
  • Phase 1
    ERSM-5404
    Colorectal Cancer Hibercell Inc
  • Phase 1
    EV68-228-N
    Flaccid Paralysis KBio Inc
  • Phase 1
    EVOLVE-104
    Anal Cancer EvolveImmune Therapeutics Inc
  • Phase 1
    Exosome-Based Vaccine
    Coronavirus Disease 2019 (COVID-19)$CAPR CAPRICOR THERAPEUTICS, INC.
  • Phase 1
    FB-101
    Amyotrophic Lateral Sclerosis 1st Bio Therapeutics Inc
  • Phase 1
    FBHRS-001
    Atrial Fibrillation FB HRS LLC
  • Phase 1
    FHL-301
    Parkinson's Disease Forest Hills Partners Hong Kong Ltd
  • Phase 1
    FID-022
    Solid Tumor Fulgent Pharma LLC
  • Phase 1
    FMT-XBI-302
    Graft Versus Host Disease (GVHD) Shenzhen UnknownBio Biotechnology Co Ltd
  • Phase 1
    FORX-428
    Metastatic Breast Cancer FoRx Therapeutics AG
  • Phase 1
    FPI-2068
    Metastatic Colorectal Cancer Fusion Pharmaceuticals Inc
  • Phase 1
    FS-120
    Advanced Malignancy invoX Pharma Ltd
  • Phase 1
    FT-522
    B-Cell Non-Hodgkin Lymphoma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-576
    Refractory Multiple Myeloma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-819
    Idiopathic Inflammatory Myopathy (IIM)$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-825
    Colorectal Cancer$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-836
    Breast Cancer$FATE FATE THERAPEUTICS INC
  • Phase 1
    G-207
    Anaplastic Astrocytoma Treovir LLC